D. Boral Capital reissued their buy rating on shares of Medicus Pharma (NASDAQ:MDCX – Free Report) in a research report released on Monday,Benzinga reports. Separately, Zacks Research upgraded shares of Medicus Pharma to a “hold” rating in a research note on Monday, September 15th. According to MarketBeat, Medicus Pharma presently has a consensus rating of “Buy” and an average target price of $23.50. Get Medicus Pharma alerts:View Our Latest Stock Analysis on Medicus PharmaMedicus Pharma Stock PerformanceMDCX stock opened at $2.51 on Monday. Further ReadingReceive News & Ratings for Medicus Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicus Pharma and related companies with MarketBeat.com's FREE daily email newsletter.